IndiaInfoline » Markets » GLENMARK

Glenmark Pharmaceuticals Ltd - Share Price

GLENMARK

Open

483.00

Prev. Close

482.55

Turnover (lac.)

8,112

Day's High

489.55

Day's Low

471.25

52 Week's High

573.05

52 Week's Low

161.65

Book Value

485

Face Value

1

Mkt Cap (Cr.)

13,685

P/E

8.78

EPS

54.98

Divi. Yield

0.52

Glenmark Pharmaceuticals LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Glenmark Pharmaceuticals LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd490.9039.41117,435.45531.950.822,878.64101.68
Dr Reddys Laboratories Ltd5,115.5025.4685,030.94950.200.493,244.40919.75
Divis Laboratories Ltd3,036.7050.8781,271.88492.250.521,709.96275.61
Cipla Ltd759.7027.8062,104.11610.300.523,035.72215.83
Biocon Ltd439.95146.0451,348.0084.800.00520.7062.80

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Glenmark Pharmaceuticals LtdSummary & Reports

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in var... More

Registered Office

B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai, Maharashtra,400026

Tell. : +91-22-40189999
Website : http://www.glenmarkpharma.com
Email : complianceofficer@glenmarkpharma.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

Latest Release by glenmark-pharmaceuticals-ltd

View

- <

Reco. Price

Sep 01,2020 05:36 PM

Target Price

Target Returns:

0.00%

Result Express

Glenmark Pharmaceuticals Ltd's Q2FY19 consolidated net profit rises 15.27% yoy to Rs246.82cr : Beats Estimates

Sep 28, 2020 11:47 AM

The company’s consolidated revenue stood at Rs2,581.33cr, up 14.39% yoy and 19.2% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    26 Jun 2020

    Effective. Date

    17 Sep 2020

    Divi. Type

    Final

    Divi.(%)

    250

    Divi. Amt.

    2.5

    Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meet... More

  • Purpose

    Board Meeting

    Exp. Date

    14 Aug 2020

    Annc. Date

    05 Aug 2020

    GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More

  • Purpose

    Board Meeting

    Exp. Date

    26 Jun 2020

    Annc. Date

    17 Jun 2020

    GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More